Search - tctmd.com

Displaying 681 - 693 of 693

Sort: Relevancy | Date

News Industry News

Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease

April 07, 2011

News Industry News

AngioScore Launches New Longer AngioSculpt(R) Devices For Treatment Of Peripheral Artery Disease

April 03, 2011

News Daily News

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Jason Kahn

March 31, 2011

News Industry News

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

March 28, 2011

News Daily News

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Caitlin E. Cox

March 18, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Daily News

Steady Decline Seen in PCI Use Over Last Few Years

L.A. McKeown

February 21, 2011

News Daily News

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

February 13, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Industry News

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

January 09, 2011

News Daily News

Technical, Anatomic Factors Could Aid Patient Selection for Carotid Stenting

Jason Kahn

January 05, 2011

News Daily News

Percutaneous Pulmonary Valve Demonstrates Encouraging Short-term Results

Jason Kahn

July 22, 2010

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

September 26, 2019

Advertisement

Spectranetics To Initiate Landmark Randomized Study Of Laser Treatment For Peripheral Artery Disease

AngioScore Launches New Longer AngioSculpt(R) Devices For Treatment Of Peripheral Artery Disease

Mortality Benefit with Primary PCI vs. Thrombolysis Restricted to High-Risk Patients

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

Meta-analysis: Renal Intervention Reduces BP Drugs, Not Outcomes

Paclitaxel-Eluting Balloon Effective for DES Restenosis

Steady Decline Seen in PCI Use Over Last Few Years

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Boston Scientific Completes Enrollment in Clinical Trial Evaluating Next-Generation Nitinol Stent to Treat Iliac Artery Disease

Technical, Anatomic Factors Could Aid Patient Selection for Carotid Stenting

Percutaneous Pulmonary Valve Demonstrates Encouraging Short-term Results

Dr. C. Michael Gibson Talks With Dr. Kenneth Ouriel About LEVANT: 5-Year Outcomes From Three Randomized Trials of Percutaneous Angioplasty With vs. Without a Drug-Coated Balloon in Patients With Femoropopliteal Arterial Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content